Ratings by B.Riley (William Wood)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/20/2026 | Alpha Cognition Inc | ACOG | New Coverage | Buy (N/A) |
8.57 (8.90) |
3.85% | Details | |
| 7/23/2026 | Agomab Therapeutics | AGMB | New Coverage | Buy (N/A) |
11.60 (13.94) |
20.17% | Details | |
| 6/5/2026 | iBio, Inc. | IBIO | New Coverage | Buy (N/A) |
1.93 (1.23) |
-36.27% | Details | |
| 5/22/2026 | Immunic Inc. | IMUX | Maintain | Buy (N/A) |
|
Details | ||
| 5/15/2026 | Aardvark Therapeutics Inc | AARD | Maintain | Buy (N/A) |
|
Details | ||
| 4/16/2026 | Equillium | EQ | New Coverage | Buy (N/A) |
2.05 (2.42) |
18.05% | Details | |
| 3/24/2026 | Aardvark Therapeutics Inc | AARD | Maintain | Buy (N/A) |
|
Details | ||
| 1/28/2026 | Aardvark Therapeutics Inc | AARD | New Coverage | Buy (N/A) |
14.76 (5.01) |
-66.06% | Details | |
| 1/9/2026 | Palisade Bio Inc. | PALI | New Coverage | Buy (N/A) |
2.02 (2.01) |
-0.5% | Details | |
| 12/7/2025 | OKYO Pharma Ltd. | OKYO | New Coverage | Buy (N/A) |
2.01 (1.43) |
-28.86% | Details | |
| 9/2/2025 | Immunic Inc. | IMUX | Maintain | Buy (N/A) |
|
Details | ||
| 5/23/2025 | Immunic Inc. | IMUX | Maintain | Buy (N/A) |
|
Details | ||
| 8/27/2024 | Immunic Inc. | IMUX | New Coverage | Buy (N/A) |
1.46 (11.84) |
710.96% | Details | |
| 8/8/2024 | LifeMD Inc | LFMD | Maintain | Buy (N/A) |
|
Details | ||
| 5/14/2024 | Veru, Inc. | VERU | New Coverage | Buy (N/A) |
1.33 (2.50) |
87.97% | Details | |
| 3/12/2024 | LifeMD Inc | LFMD | Maintain | Buy (N/A) |
|
Details | ||
| 12/12/2023 | Koru Medical Systems Inc. | KRMD | New Coverage | Buy (N/A) |
2.30 (3.15) |
36.96% | Details | |
| 12/1/2023 | Clearpoint Neuro Inc. | CLPT | New Coverage | Buy (N/A) |
5.76 (13.48) |
134.03% | Details | |
| 12/1/2023 | LifeMD Inc | LFMD | New Coverage | Buy (N/A) |
7.70 (3.03) |
-60.65% | Details |
